CSF1 and neoplasm: Given that CSF-1 is increased by cisplatin treatment, and that the CSF-1Rpos cells are chemoresistant, important to evaluate which signals modulate the expression of CSF-1 and CSF-1R within the context of a stress induced tumor rearrangement and whether the CSF-1R ligand may work as a SASP cytokine.